Home Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute
 

Keywords :   


Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute

2016-03-25 15:53:27| Biotech - Topix.net

The damages award is far less than the $2 billion Merck had demanded. On Tuesday, the same jury in San Jose, California, upheld the validity of the patents, which lie at the heart of the dispute over Gilead's blockbuster drugs Sovaldi and Harvoni.

Tags: pay million drug ordered

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
07.11Hurricane Rafael Graphics
07.11Hurricane Rafael Wind Speed Probabilities Number 14
07.11Hurricane Rafael Forecast Discussion Number 14
07.11Hurricane Rafael Forecast Advisory Number 14
07.11Hurricane Rafael Public Advisory Number 14
07.11Tropical Depression Fourteen-E Graphics
07.11Tropical Depression Fourteen-E Forecast Discussion Number 3
07.11Tropical Depression Fourteen-E Wind Speed Probabilities Number 3
More »